Health ❯ Vaccines

Flu Vaccine

Public Health Recommendations FluMist FDA Approval FDA Advisory Panel mRNA Technology Vaccine Hesitancy Moderna Nasal Spray Effectiveness Over Time mRNA Vaccines AstraZeneca Effectiveness

FDA Reverses Course To Review Moderna’s mRNA Flu Shot Under Split Pathway

The reversal follows a rare refusal-to-file over the trial comparator for seniors, with a decision due August 5.

AstraZeneca Launches FluMist Home Direct-to-Consumer Nasal Vaccine in 34 States